Labcorp扩大PathAI合作伙伴关系，在全国部署数字病理平台

2026-02-23 20:27

Labcorp (LH) on Monday said it will expand its collaboration with PathAI to deploy the FDA-cleared AISight Dx digital pathology platform across its national network of anatomic pathology labs and hospital collaborations.
Labcorp said the cloud-based platform will support fully digital workflows for slide review, case management and collaboration, and integrate AI-powered image analysis to assist in diagnostics.
The company said it will also incorporate digital pathology workflows to support its precision medicine products.
The expansion builds on Labcorp’s 2019 strategic investment in PathAI and follows ongoing collaboration in AI-driven clinical trial support and validation of AI-pathology solutions.
LH +1.59% premarket to $287.17.
Source: Press Release

More on Labcorp Holdings